This article presents an overview of 5 Buy-Rated Stocks with Latest Insider Purchases. For a detailed overview of such stocks read our article, 10 Buy-Rated Stocks with Latest Insider Purchases.
5. Oncternal Therapeutics Inc (NASDAQ:ONCT)
Average Analyst Price Target: $31.33
Upside Potential: 252%
Robert James Wills, a director at Oncternal Therapeutics Inc (NASDAQ:ONCT), bought 3,086 shares of Oncternal Therapeutics Inc (NASDAQ:ONCT) at $8.96 per share. The total value of this transaction was $27,655. The transaction took place on April 8. Since then the stock is up 3%.
As of the end of the fourth quarter of 2023, four hedge funds tracked by Insider Monkey reported owning stakes in the oncology-focused biotech company Oncternal Therapeutics Inc (NASDAQ:ONCT). Over the past one year the stock has gained about 60% in value.
4. Anixa Biosciences Inc (NASDAQ:ANIX)
Average Analyst Price Target: $12
Upside Potential: 278%
On April 9, 2024, Lewis H. Titterton Jr., a one of the directors at Anixa Biosciences Inc (NASDAQ:ANIX), piled into 15,009 shares at $3.28 per share. The total value of this transaction was $49,230 per share. Since the date of this transaction Anixa Biosciences Inc (NASDAQ:ANIX) stock has lost about 2.5% in value.
3. Dominari Holdings Inc (NASDAQ:DOMH)
Average Analyst Price Target: $16
Upside Potential: 444%
Biotechnology company Dominari Holdings Inc (NASDAQ:DOMH) ranks third in our list of the buy-rated stocks corporate insiders are buying. Dominari Holdings Inc’s (NASDAQ:DOMH) President and 10% stake owner Kyle Wool on April 8 snapped up 4,250 shares of Dominari Holdings Inc (NASDAQ:DOMH) at $2.99 per share. Since then the stock has gained about 3.18%. Wool also amassed 9,500 shares of Dominari Holdings Inc (NASDAQ:DOMH) on April 4 at $2.84 per share.
2. Widepoint Corp (NYSE:WYY)
Average Analyst Price Target: $14
Upside Potential: 514%
Technology company Widepoint Corp (NYSE:WYY) ranks second in our list of the buy-rated stocks insiders are piling into. Widepoint Corp’s (NYSE:WYY) CEO Jin Kang on April 10 bought 2,000 shares of Widepoint Corp (NYSE:WYY) at $2.28 per share. Since then the stock is down 2.64%. Widepoint Corp’s (NYSE:WYY) EVP and Chief Sales Officer Jason Holloway also bought 1,000 shares of Widepoint Corp (NYSE:WYY) on April 10.
1. BioRestorative Therapies Inc (NASDAQ:BRTX)
Average Analyst Price Target: $12.5
Upside Potential: 830%
BioRestorative Therapies Inc (NASDAQ:BRTX) is working on cell-based therapies to treat chronic lumbar disc disease and metabolic conditions. According to Yahoo Finance data the average analyst price estimate for the stock is about $12. It was trading at $1.33 as of April 12.
On April 8, BioRestorative Therapies Inc’s (NASDAQ:BRTX) VP of R&D Francisco Silva snapped up 8,308 shares of BioRestorative Therapies Inc (NASDAQ:BRTX) at $1.23 per share. Since then the stock has gained about 4.7%.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the 10 Underperforming Stocks Insiders are Buying and the Insiders Are Buying These 11 Penny Stocks.
